Information for the user Boots Indigestion Relief Tablets Fruit (Calcium Carbonate) Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription to treat minor conditions. However, you still need to take it carefully to get the best results from it. • Keep this leaflet, you may need to read it again • Ask your
Plunketts.netAL SAFETY DATA SHEET
MSDS Ref. No: 074
Revision No: 3
1. PRODUCT AND COMPANY IDENTIFICATION
PRODUCT NAME: VAP-5 PRODUCT
DESCRIPTION: Liquid Insecticide PRODUCT CODE: #71
EPA REG. NO. : 47000-71
MANUFACTURER 24 HR. EMERGENCY TELEPHONE NUMBERS
CHEMTREC U.S. and CANADA:(800) 424-9300
CHEMTREC All Other Areas:(703) 527-3887
For information regarding MEDICAL EMERGENCIES or PESTICIDE INCIDENTS, call the INTERNATIONAL POISON 2. COMPOSITION / INFORMATION ON INGREDIENTS
Dichlorvos (DDVP) Dimethyl 2,2-diclorovinylphosphate COMMENTS: Ingredients not identified are proprietary or non-hazardous. Values are not product specifications.
3. HAZARDS IDENTIFICATION
IMMEDIATE CONCERNS: DANGER – POISON. Fatal if swallowed, inhaled or absorbed through skin and eyes. Rapidly
absorbed through skin. Do not get in eyes, on skin or on clothing. Do not breathe vapor or spray mist. Repeated inhalation or skin contact may, without symptoms, progressively increase susceptibility to Dichlorvos (DDVP) poisoning. Combustible. DO NOT use or store near heat, sparks, open flame, or any other ignition sources. POTENTIAL HEALTH EFFECTS
EYES: Eye irritant.
SKIN ABSORPTION: May be fatal if absorbed through the skin.
INGESTION or INHALATION: May be fatal if swallowed or inhaled.
SIGNS OF ACUTE OVEREXPOSURE: Acute cholinesterase depression may be evidenced by headache, nausea,
vomiting, diarrhea, abdominal cramps, excessive sweating, salivation and tearing, constricted pupils, blurred vision,
tightness in chest, weakness, muscle twitching and confusion. In extreme cases, unconsciousness, convulsions,
severe respiratory depression and death may occur.
SIGNS OF CHRONIC OVEREXPOSURE: Repeated exposure to small doses of Dichlorvos and other
organophosphates may lower the cholinesterase to levels where the above symptoms of acute overexposure are
4. FIRST AID MEASURES
EYES: Immediately hold eye open and rinse slowly and gently with water for 15-20 minutes. Remove contact lenses, if
present, after the first 5 minutes, then continue rinsing eye. Call a poison control center or doctor for treatment advice. SKIN: Take off contaminated clothing. Rinse skin immediately with plenty of water for 15-20 minutes. Call a poison
control center or doctor for treatment advice. INGESTION: If swallowed, IMMEDIATELY call a poison control center or doctor for treatment advice. Do not induce
vomiting unless told to do so by a poison control center or a doctor. Do not give any liquid to the person. Never give anything by mouth to an unconscious person. Page 1 of 5
INHALATION: Remove affected person to fresh air. If person is not breathing, call 911 or an ambulance, then give artificial
respiration, preferably mouth-to-mouth if possible. Call a poison control center or doctor for further treatment advice. NOTES TO PHYSICIAN: This is an Organophosphate (OP) Insecticide. Do not wait for laboratory confirmation to
treat patients with strong clinical evidence of poisoning. IV Atropine sulfate is the antidote of choice against parasympathetic nervous stimulation. If there are signs of parasympathetic stimulation , Atropine Sulfate should be injected at 10 minute intervals in doses of 1 to 2 milligrams until complete atropinization has occurred. Pralidoxime chloride (2-PAM chloride) may also be used as an effective antidote in addition to and while maintaining full atropinization. In adults, an initial dose of 1 gram of 2-PAM should be injected, preferably as an infusion, in 250 cc of saline over a 15 to 20 minute period. If this is not practical, 2-PAM may be administered slowly by intravenous injection as a 5% solution in water over not less than 2 minutes. After an hour, a second dose of 1 gram of 2-PAM will be indicated if muscle weakness has not been relieved. For infants and children, the dose of 2-PAM is 0.25 grams. Avoid morphine, aminophylline, phenothiazine, reserpine, furosemide and ethacrynic acid. Clear chest by postural drainage. Oxygen administration may be necessary. Observe patient continuously for 48 hours. Repeated exposure to cholinesterase inhibitors may without warning cause prolonged susceptibility to very small doses of any cholinesterase inhibitor. Allow no further exposure until time for cholinesterase regeneration has been attained as determined by a blood test. Probable mucosal damage may contraindicate the use of gastric lavage. 5. FIRE FIGHTING MEASURES
FLASH POINT: 112° F TCC
FLAMMABLE LIMITS: LEL: 1.9 UEL: 12.6
EXTINGUISHING MEDIA: Foam, carbon dioxide water fog or dry chemical.
HAZARDOUS COMBUSTION PRODUCTS: This product is classified as Non-Combustible, however in the extreme
temperatures that fires may product, some of the constituents of this formula may decompose to give off such gases as carbon monoxide, carbon dioxide, and nitrogen oxides. EXPLOSION HAZARDS: With sufficient heat or burning, toxic vapors are emitted. Treat as flammable liquid.
FIRE FIGHTING PROCEDURES: Treat as an oil fire. Use a full-faced self-contained breathing apparatus along with full
protective gear. Keep nearby containers and equipment cool with a water stream. SENSITIVITY TO IMPACT: None
ACCIDENTAL RELEASE MEASURES
SMALL SPILL: Stop release, if possible without risk. Dike or contain release, if possible, and if immediate response can
prevent further damage or danger. Isolate and control access to the release area. Take actions to reduce vapors. Absorb with
appropriate absorbent. Clean spill area of residues and absorbent.
LARGE SPILL: Stop release, if possible without risk. Dike or contain release, if possible, and if immediate response can
prevent further damage or danger. Isolate and control access to the release area. Take actions to reduce vapors. Collect product into drums, etc. via drains, pumps, etc. Absorb with appropriate absorbent. Clean spill area of residues and absorbent. 7. HANDLING AND STORAGE
GENERAL PROCEDURES: Do not contaminate water, food or feed by storage or disposal.
STORAGE: Store in a secure area preferably under lock and key. Storage area should be equipped to handle an accidental
Page 2 of 5
8. EXPOSURE CONTROLS / PERSONAL PROTECTION
OSHA HAZARDOUS COMPONENTS (29 CFR 191 0.1200)
mg/m3 ppm mg/m3
ENGINEERING CONTROLS: Ventilate treatment area thoroughly before re-entry. Use of mechanical or local exhaust
PERSONAL PROTECTIVE EQUIPMENT:
Applicators and other Handlers must wear: Coveralls over long sleeved shirt and long pants; Chemical resistant gloves
such as Barrier Laminate, Butyl Rubber, Nitrile Rubber, Neoprene Rubber, Polyvinyl Chloride or Viton; Chemical
resistant footwear plus socks; Protective Eyewear; Chemical resistant headgear for overhead exposure.
RESPIRATORY: Respirator with either an organic vapor removing cartridge with a prefilter approved for pesticides
(MSHA/NIOSH approval number TX-23C) or a canister approved for pesticides (MSHA/NIOSH approval number TC-14G or
a NIOSH approved respirator with an organic vapor (OV) cartridge or canister with any R, P, or HE prefilter.
WORK HYGIENIC PRACTICES: DO NOT SMOKE, EAT, OR DRINK, OR APPLY COSMETICS IN WORK AREA!
Discard clothing and other absorbent materials that have been heavily contaminated with this product. Do not reuse them. Follow manufacturer’s instructions for cleaning and maintaining PPE. If no such instructions for washables, use detergent and hot water. Keep and wash PPE separately from other laundry. Wash promptly if skin becomes contaminated. Wash at the end of each work shift and before eating, drinking, chewing gum, using tobacco, or using the toilet. 9. PHYSICAL AND CHEMICAL PROPERTIES
PHYSICAL STATE: Clear Liquid
ODOR: Petroleum odor.
pH: Not Determined
VAPOR PRESSURE: .>1 @ 20° C
VAPOR DENSITY: >1 (Air=1)
BOILNG POINT: Not Available
FREEZING POINT: Not Available
SOLUBILITY IN WATER: Insoluble
EVAPORATION RATE: Not Available
SPECIFIC GRAVITY: 0.81 (Water = 1) at 20°C (68°F)
VISCOSITY: 1.37 CPS @ 25° C
HAZARDOUS POLYMERIZATION: No
CONDITIONS TO AVOID: Not compatible with strong acids or bases. Not compatible with strong oxidizers.
11. TOXICOLOGICAL INFORMATION: Acute and chronic toxicity listed below is for Dichlorvos Technical.
Oral LD50 (rat): 56 mg/kg
Dermal LD50 (rabbit): 205 mg/kg
Inhalation LC50 (rat): 140 mg/m3 (whole body, mist)
Irritation: Skin and Eye irritant
Sensitization: Skin (Guinea pig): Possible sensitizer
Teratogenicity: No evidence of teratogenicity in laboratory animals.
Page 3 of 5
Mutagenicity: No invivo mutagenicity activity in mammalian assay systems.
Carcinogenicity: EPA has classified Dichlorvos as being in Category C, a possible carcinogen. IARC lists
Dichlorvos as being possibly carcinogenic to humans (Group 2B).
Reproductive Toxicity: Reproductive effects have only been seen at a dose level which produces a generalized
toxicity in the rat.
12. ECOLOGICAL INFORMATION ENVIRONMENTAL DATA: Environmental data not available for this product.
ECOTOXICOLOGICAL INFORMATION: This product is toxic to aquatic invertebrates, fish, birds and other wildlife. Do not
contaminate water when disposing of equipment wash waters. 13. DISPOSAL CONSIDERATIONS
DISPOSAL METHOD: Pesticide wastes are acutely hazardous. If these wastes cannot be disposed of by use according to
label instructions, contact your State Pesticide or Environmental Control Agency, or the Hazardous Waste representative at the nearest EPA Regional Office for guidance. EMPTY CONTAINER: Nonrefillable container. Do not reuse or refill this container. Triple rinse container (or
equivalent) promptly after emptying. Offer for recycling if available. Triple rinse as follows: Empty the remaining contents into application equipment or mix tank and drain for 10 seconds after the flow begins to drip. Fill container ¼ full with appropriate spray oil and recap. Shake for 10 seconds. Pour rinsate into application equipment or mix tank or store rinsate for later use or disposal. Drain for 10 seconds after the flow begins to drip. Repeat this procedure two more times. 14. TRANSPORT INFORMATION
DOT (DEPARTMENT OF TRANSPORTATION)
PROPER SHIPPING NAME: HM, ORGANOPHOSPHORUS PESTICIDES, LIQUID, TOXIC, FLAMMABLE, 6.1(3), UN3017,
PRIMARY HAZARD CLASS/DIVISION: 6.1
UN/NA NUMBER: UN3017
DOT LABELING: Poison 6, PG III. FLAMMABLE LIQUID 3
AIR (ICAO/IATA) N/A
PROPER SHIPPING NAME: N/A
PRIMARY HAZARD CLASS/DIVISION: N/A
UN/NA NUMBER: N/A
PROPER SHIPPING NAME:
15. REGULATORY INFORMATION
SARA TITLE III (SUPERFUND AMENDMENTS AND REAUTHORIZATION ACT)
311/312 HAZARD CATEGORIES:
FIRE: No PRESSURE GENERATING: No REACTIVITY: No IMMEDIATE HEALTH HAZARD: Yes
DELAYED HEALTH HAZARD: Yes
CERCLA REPORTABLE QUANTITIES (RQ): Dichlorvos, CAS# 62-73-7, 10 lbs.; Product: 200 lbs.
302/304 EMERGENCY PLANNING
EMERGENCY PLAN: Dichlorvos (DDVP) CAS # 62-73-7
313 TOXIC CHEMICALS: Dichlorvos (DDVP) CAS # 62-73-7
16. OTHER INFORMATION
HMIS RATING: 4 – 0 – 0
NFPA RATING: 4 – 0 – 0
HMIS RATINGS NOTES: We assign HMIS ratings to this product based on the hazards of its ingredients(s). Since the
Page 4 of 5
customer is most aware of the applications and conditions of use, he or she must ensure that the proper Personal Protective Equipment is provided, consistent with the information contained in Section's 7 and 8 of this MSDS. COMMENTS: The data contained herein are based on information currently available to Chem-Tech, Ltd and, to the best of our
knowledge, are accurate and based on sound expert opinion. Our statements herein, however, are not to be taken as a warranty or representation for which the Manufacturer assumes legal responsibility. Prepared by: Steve Rogosheske, CTL Regulatory Dept. Page 5 of 5
PRAIRIE SHOULDER, ELBOW & HAND CENTER 1. It is the patient’s responsibility to get pre-certification from your insurance company for your surgical procedure. At this time, if you will need Physical Therapy, please verify the number of visits allowed. 2. Make an appointment for your preoperative history & physical with your personal physician. This needs to be completed within 30